Search by Drug Name or NDC
NDC 75834-0294-01 Erythromycin Ethylsuccinate 400 mg/5mL Details
Erythromycin Ethylsuccinate 400 mg/5mL
Erythromycin Ethylsuccinate is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Nivagen Pharmaceuticals, Inc.. The primary component is ERYTHROMYCIN ETHYLSUCCINATE.
Product Information
| NDC | 75834-0294 |
|---|---|
| Product ID | 75834-294_46f74c4f-10fc-44cf-aec4-d113f49149bc |
| Associated GPIs | |
| GCN Sequence Number | 021206 |
| GCN Sequence Number Description | erythromycin ethylsuccinate SUSP RECON 400 MG/5ML ORAL |
| HIC3 | W1D |
| HIC3 Description | MACROLIDE ANTIBIOTICS |
| GCN | 40524 |
| HICL Sequence Number | 004018 |
| HICL Sequence Number Description | ERYTHROMYCIN ETHYLSUCCINATE |
| Brand/Generic | Generic |
| Proprietary Name | Erythromycin Ethylsuccinate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Erythromycin Ethylsuccinate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION |
| Route | ORAL |
| Active Ingredient Strength | 400 |
| Active Ingredient Units | mg/5mL |
| Substance Name | ERYTHROMYCIN ETHYLSUCCINATE |
| Labeler Name | Nivagen Pharmaceuticals, Inc. |
| Pharmaceutical Class | Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA216212 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 75834-0294-01 (75834029401)
| NDC Package Code | 75834-294-01 |
|---|---|
| Billing NDC | 75834029401 |
| Package | 100 mL in 1 BOTTLE (75834-294-01) |
| Marketing Start Date | 2023-02-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 2.68753 |
| Pricing Unit | ML |
| Effective Date | 2023-05-10 |
| NDC Description | ERYTHROMYCIN 400 MG/5 ML SUSP |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis